Milestone for Cardiff anti-shingles drug
16/12/2010
Pharmaceutical company Inhibitex Inc has reported promising results from the phase 2 trial of FV-100, the anti-shingles drug developed in collaboration with Professor Chris McGuigan's research group at Cardiff University.
First Minister to open flagship cancer genetics building
29/11/2010
A new high-tech home for Wales’ to advance the genetic fight against cancer and other inherited diseases will be officially opened by Rt. Hon Carwyn Jones, First Minister of Wales on Thursday 2nd December between 3-4pm.